Dan DeBonis is one of the pioneers and leaders at the forefront of innovation for eCOA, outcome analytics and the integration of digital technologies in clinical research. He is an entrepreneur, a co-founder of several companies, including Concordant Rater Systems, which became part of what is now Signant Health in 2010. Throughout his career, he has integrated key stakeholders, including clinicians, developers, KOLs, patients and regulators, into technology driven solutions to improve the quality and integrity of clinical trial data. More recently, Dan has been a leader on COVID-19 response and mitigation strategies for Signant Health and our clients. He has served as an advisor to a range of companies from start-ups to large pharmaceutical companies. Dan is the author of a patent and publications on technologies in clinical research. He is a graduate of Yale University, and resides with his young family in Boston.
Dan DeBonis
